For: | Krastev Z, Koltchakov V, Tomova R, Deredjian S, Alexiev A, Popov D, Tomov B, Koten JW, Jacobs J, Otter WD. Locoregional IL-2 low dose applications for gastrointestinal tumors. World J Gastroenterol 2005; 11(35): 5525-5529 [PMID: 16222748 DOI: 10.3748/wjg.v11.i35.5525] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i35/5525.htm |
Number | Citing Articles |
1 |
Suyog Shaha, Danika Rodrigues, Samir Mitragotri. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation. Journal of Controlled Release 2024; 367: 737 doi: 10.1016/j.jconrel.2024.01.072
|
2 |
Cong-Jun Wang, Chao Wang, Jiang Han, Yong-Kun Wang, Lin Tang, Dong-Wei Shen, Yi Zhao, Rong-Hua Xu, Hui Zhang. Effect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancer. Molecular Biology Reports 2013; 40(12): 6579 doi: 10.1007/s11033-013-2766-1
|
3 |
Mohamed A. Shaker, Husam M. Younes. Interleukin-2: Evaluation of Routes of Administration and Current Delivery Systems in Cancer Therapy. Journal of Pharmaceutical Sciences 2009; 98(7): 2268 doi: 10.1002/jps.21596
|
4 |
Lindsay Kathleen Dickerson, Jason A Carter, Karan Kohli, Venu G Pillarisetty. Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumours. Gut 2023; 72(8): 1592 doi: 10.1136/gutjnl-2023-329650
|
5 |
Willem Den Otter, John J. L. Jacobs, Jan J. Battermann, Gerrit Jan Hordijk, Zachary Krastev, Ekaterina V. Moiseeva, Rachel J. E. Stewart, Paul G. P. M. Ziekman, Jan Willem Koten. Local therapy of cancer with free IL-2. Cancer Immunology, Immunotherapy 2008; 57(7): 931 doi: 10.1007/s00262-008-0455-z
|